It’s just a proposal but Biden administration’s plan argues for adding wind power stocks right now–here are five picks

It’s just a proposal but Biden administration’s plan argues for adding wind power stocks right now–here are five picks

Today, May 29, the Biden administration announced an ambitious plan to expand wind farms along the East Coast. The goal would be to see the United States produce 30 gigawatts of offshore wind power by 2030. That’s just a little ambitious since U.S. offshore wind power production right now is 30 megawatts (a gigawatt is 1,000 megawatts) from one wind farm off Rhode Island. Europe, in contrast, already has 24 gigawatts in operation, and the United Kingdom aims to have 40 gigawatts online by 2030Besides generating enough power for 10 million U.S. homes, the plan would cut 78 million metric tons of carbon dioxide emissions.

Trick or trend: The chip shortage is getting worse–just in time for earnings reports in April

Trick or trend: The chip shortage is getting worse–just in time for earnings reports in April

Car makers have put investors on notice that a severe shortage of chips is forcing them to curtail production. Volkswagen, Toyota, and General Motors have all reported halting production due to a shortage of silicon and the companies have suspended forecasts of manufacturing volumes because of the shortage. Volkswagen, for example expects a drop in production of 100,000 cars in the first quarter. Electric car maker Nio has suspended production at its Chinese plant for 5 days due to the shortage. And the shortage looks to be getting worse.

Buying “vaccine rally” stock Wyndham Hotels in Jubak Picks Portfolio

Wyndham Hotels and Resorts is a relative bargain for anyone looking to profit from the “vaccine rally.” The stock is up only 19.9% for 2021 as of the close on March 16. Most of that (18.4%) has come in the last one one month. Given the likely resurgence in travel and Wyndham’s focus on the leisure travel market in the low to medium priced segment, I think the stock has more room to run. I’ll be buying the shares tomorrow for my Jubak Picks Portfolio with a target price of $84 a share. The stock closed at $70.41 today, March 16.

My nibbles in today’s “Everything is down” market

My nibbles in today’s “Everything is down” market

Last time, way back on February 23, when I posted on an everything is down market, I said that I didn’t think we were yet at buy on the dip time, but that I was doing a little selective nibbling at stocks such as Applied Materials (AMAT) that had extraordinarily strong 2012 growth stories. Well, I’ve been doing a little nibbling today–again I’m not buying everything on the drop since I can’t tell where the bottom might be.

So what’s the matter with Incyte stock? Just about nothing although you wouldn’t know it from the recent price movement

So what’s the matter with Incyte stock? Just about nothing although you wouldn’t know it from the recent price movement

Shares of biotech stock Incyte (INCY) have been down significantly in 2021. For the year to date, as of the close on March 2, the shares were down 8.45%. In the last month they’ve tumbled 12.42%. So what’s wrong? Pretty much nothing. With the individual stock anyway. What we’re watching is a lot of selling in the biotech sector as part of the recent sell-off on risk. And on substantial profit taking.

Keeping Palo Alto Networks with a big boost to my target price

Keeping Palo Alto Networks with a big boost to my target price

After the close on Monday February 22 Palo Alto Networks (PANW) reported a loss of $1.42 million (or $1.48 a share) on revenue of $1.02 billion million for the company’s fiscal second quarter. Adjusted earnings–which exclude share-based compensation and other items, were $1.53 a share. Revenue grew by 25% year over year. Wall Street had been looking for adjusted earnings of $1.43 a share on revenue of $986 million. Billings for future orders ross to $1.21 billion from $999 in the year ago wearer. Analysts had forecast billings of $1.18 billion. But the shares fell in after hours trading when in its conference call the company forecast adjusted earnings of $1.27 to $1.29 a share on revenue of $1.05 to $1.06 billion for the fiscal third quarter. Analysts were looking for adjusted earnings of $1.29 a share on revenue of $1.05 billion for the fiscal third quarter. For the full fiscal year Palo Alto Networks forecast adjusted earnings of $5.80 to $5.90 a share on revenue of $4.15 billion to $4.2 billion. Wall Street had been looking for $5.79 a share in adjusted earnings on revenue of $4.12 for the year. On the plus side of the ledger there are two reasons that I’m keeping this company in my Jubak Picks Portfolio and my long-term 50 Stocks Portfolio

Special Report: Profit and Protect–What you need to know about stock market stages for 2021–Stage 2 of 3: My rules for selling in the “When you win, you lose market” (and sells of ILMN, CTVA, WST, and VMW)

Special Report: Profit and Protect–What you need to know about stock market stages for 2021–Stage 2 of 3: My rules for selling in the “When you win, you lose market” (and sells of ILMN, CTVA, WST, and VMW)

On to Stage #2 in my Special Report: “Profit and Protect–What you need to know about stock market stages for 2021. And to my rules for the sells and hedges in Stage #2 for 2021: When you win, you lose. (I just posted sells for ILMN, CTVA, WST and VMW)

Trick or trend: The chip shortage is getting worse–just in time for earnings reports in April

Buy, sell, repeat–I’m not buying on the dip yet–but I am making a few quick trades to take advantage of the volatility; my trade today in AMAT is an example

I’m very reluctant to go bottom fishing here–since I can’t tell where the bottom might be and the one-day losses are significant here. Tesla (TSLA), for example, was down 8.06% TODAY. That’s $59.80 dollars a share. Teladoc (TDOC) dropped 13.74% or $34.98 a share. Guessing wrong on a bottom could be very expensive here. But I am willing to try a few trades. Nothing fancy. Very short-term. But using stocks with very strong longer-term stories that make me feel good about the longer-term prospects for the stocks. And to believe that there are significant numbers of potential bargain hunters hiding in the bushes. So, for example, I’ve been trading in and out of the Call Options on Applied Materials (AMAT).

Xylem is my 10th Special Report: Profit and Protect pick on the climate change trend

Xylem is my 10th Special Report: Profit and Protect pick on the climate change trend

I’m making Xylem (XYLEM) the 10th and last pick for Stage 1 in my Special Report on the stock market stages for 2021. The stock fills the final slot in my three picks for the climate change trend. The collapse of the energy delivery system in the deep freeze that killed so many people and disrupted the economy from Texas east to Ohio has received the bulk of the headlines. But the stories about families left without drinking water–or indeed water of any sort–should remind us that climate change is also a water crisis.